Edwards gains surprise US injunction against Medtronic's CoreValve
This article was originally published in Clinica
Executive Summary
The long-running court battle between Edwards Lifesciences and Medtronic over their transcatheter aortic valve implant (TAVI) devices has taken an unexpected twist: Edwards has been granted a preliminary US injunction against its rival.